Clinical Specialties

Advanced Molecular Diagnostics for Oncology

Cancer care requires precision, speed, and clarity. Chronetyx provides highly sensitive molecular testing designed to support oncologists in both infection management and tumor profiling, helping clinicians make confident, timely decisions that improve patient outcomes.

Our laboratory combines fully automated advanced Next-Generation Sequencing (NGS) capabilities for tumor profiling and infectious disease PCR diagnostics to support comprehensive oncology care.

Oncology-specific services include:

• Solid Tumor NGS (Cyx Solid Tumor 505 Panel)
• Infectious Disease Testing (Respiratory, Urine, Wound)

Solid Tumor Genomic Profiling

Cyx Solid Tumor 505 Panel

Comprehensive tumor profiling for precision oncology.

Our Next-Generation Sequencing platform analyzes:

• 505 solid tumor–related genes
• FDA-approved and guideline-supported biomarkers
• MSI and TMB
• SNVs, indels, translocations, and amplifications
• 35+ tumor types across 9 organ systems

Benefits:

• Helps identify targeted therapy options
• Supports immunotherapy eligibility
• Enables personalized treatment planning
• Offers rapid results (within a week)
• Built on FDA-cleared and CE-IVD–marked chemistry
• Ultra-high average coverage (~2,300×) for accuracy
• Works with FFPE tissue (slides, blocks, etc.)

Why Oncology Teams Partner With Chronetyx for Infectious Disease

Fast, Actionable Results for Immunocompromised Patients

Cancer patients are at high risk for rapid-onset infections. Our PCR infectious disease panels return detailed results within a day, enabling early intervention and reduced complications.

High Sensitivity for Low-Load Infections

Immunosuppressed patients often carry low levels of pathogens. PCR detects what culture and antigen tests routinely miss.

Automation Ensures Consistency & Accuracy

Robotic processing reduces human error and delivers reproducible, high-quality results — essential for oncology decision-making.

Unaffected by Prior Antibiotics

Many patients are pre-treated or prophylactically treated. PCR remains accurate where culture fails.

Competitive Pricing

Advanced molecular clarity without higher testing costs. Ideal for outpatient oncology centers.

Infection Panels for Oncology Care

Cancer patients—especially those receiving chemotherapy, radiation, immunotherapy, or stem cell treatments—are vulnerable to infections that can escalate quickly. Our molecular diagnostics support early detection and management.

Respiratory PCR Panel

One swab detects viral and bacterial upper-respiratory pathogens.

Identifies 16 upper-respiratory pathogens including SARS-CoV-2, Influenza A/B, RSV, Human metapneumovirus, and more.

Urine PCR (UTI) Panel

High-sensitivity detection for complex or recurrent UTIs.

Detects uropathogens with reflex antibotic resistance gene testing.

Wound PCR Panel

For surgical sites, ports, radiation-damaged tissue, and chronic wounds.

Identifies pathogens and antibiotic resistance genes up to 5 days faster than culture.

The Chronetyx Advantage for Oncology

Cutting-Edge Molecular Technology

NGS + PCR integrated under one roof for both infectious and genomic needs.

Industry-Leading Turn-Around-Times

Results in days (NGS), not weeks and hours (PCR), not days.

High-Throughput Automated Workflow

Capacity to support large oncology networks and hospital systems.

In-House Informatics & EHR Integration

Clean, actionable reports delivered directly to your EMR.

Dedicated Clinical Support

Our team offers interpretation support for complex molecular findings.